Tirzepatide × NextGen Peptides - Lab Test, July 2025
Test results
About this test
This independent LC-MS lab test confirms Tirzepatide 37.7mg from NG Peptide at 99.42% purity. The analysis was conducted by BioRegen on July 1, 2025.
Tirzepatide is a dual GIP/GLP-1 receptor agonist researched for its role in metabolic regulation, weight management, and glycemic control. The tested quantity of 37.7mg significantly exceeds the stated label claim of 30mg (+25.67%), indicating above-specification formulation with consistent quality control. A purity level of 99.42% demonstrates high-grade synthesis with minimal impurities.
The lyophilized white powder was tested using ultra high-performance liquid chromatography with UV detection and mass spectrometry (LC-MS), confirming compound identity and mass with high precision. The full certificate of analysis is available for download on this page.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.